Skip to main content
Caplight Logo









Leios Therapeutics

Leios Therapeutics

Private
La Jolla, CaliforniaHealthcare & Life Scienceshttps://leiostherapeutics.com/

Last Round

Strategic

Aug 30, 2026

Total Funding Raised

$2.47M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Leios Therapeutics is a clinical-stage biotechnology company that develops innovative injectable therapies for aesthetic indications, including focal fat reduction and body contouring.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Fashion & Beauty, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

medical aestheticsinjectable therapyaesthetic medicinefat reductionbody contouringfat dissolving injectionadipolysisnon-invasive treatmentbiotechnologydrug repurposingclinical-stage biotechpharmaceutical licensingcosmetic dermatologysubmental fatpolidocanol

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Leios Therapeutics Comparables

Compare Leios Therapeutics with similar companies based on industry and business-model similarity.

Leios Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AMI Pharm Co., Ltd.
85%
Raziel Therapeutics
83%
Love Cosmedical
77%

Leios Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicAug 30, 2026
StrategicJan 26, 2026
Series BAug 23, 2021
VC RoundApr 19, 2018

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 30, 2026

    China Medical System Holdings Limited participated in the round.

  • Jan 26, 2026

    BNC Korea Co. Ltd participated in the round.

Leios Therapeutics Filings

Explore SEC and related filing metadata, where available.

Leios Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Leios Therapeutics's valuation, stock price, and market status.

Is Leios Therapeutics a public or private company?

Leios Therapeutics is a private company.

What is the current stock price of Leios Therapeutics?

Leios Therapeutics is a private company with no public stock price. Caplight tracks Leios Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Leios Therapeutics worth (valuation)?

Valuation information for Leios Therapeutics is not publicly available.

Can I buy Leios Therapeutics stock?

Leios Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Leios Therapeutics's last funding round?

Leios Therapeutics's most recent funding round was Strategic on August 30, 2026.

Who are the main investors in Leios Therapeutics?

Investor information for Leios Therapeutics is not publicly disclosed.

Will Leios Therapeutics IPO soon?

No public IPO plans have been announced for Leios Therapeutics.

How can I track Leios Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Leios Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLa Jolla, California
Year FoundedN/A
Last FundingAug 30, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?